{"entity":{"id":"nct03977194","kind":"trial","name":"Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy","aka":["ELDERLY"],"tldr":"A phase 3 trial of carboplatin, paclitaxel / nab-paclitaxel and atezolizumab in lung cancer, run by Intergroupe Francophone de Cancerologie Thoracique, active but no longer recruiting.","summary":"Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy is a phase 3, randomised interventional study registered as NCT03977194 by Intergroupe Francophone de Cancerologie Thoracique, with a registry enrolment figure of 510 participants, started 2019-07-23 and due to reach its primary completion in 2024-08-31. Interventions recorded: Carboplatin; Paclitaxel; Atezolizumab. Conditions listed: Non Small Cell Lung Cancer Metastatic. Primary outcome: Overall Survival. Lung eligibility wording from the registry: \"Histologically confirmed NSCLC\". Sites: France. No results are recorded here; the registry entry is the source.","status":"active","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT03977194","url":"https://clinicaltrials.gov/study/NCT03977194"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":["checkpoint-inhibitor","cytotoxic-chemotherapy","platinum"],"targets":[],"drugs":["carboplatin","paclitaxel","atezolizumab"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03977194","phase":"3","setting":"Phase III Randomized Trial of Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Monthly Carboplatin With Weekly Paclitaxel Chemotherapy","sponsor":"Intergroupe Francophone de Cancerologie Thoracique","enrolled":510,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03977194/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"technology":[{"id":"cytotoxic-chemotherapy","kind":"technology","name":"Cytotoxic chemotherapy","route":"/technologies/cytotoxic-chemotherapy/"},{"id":"checkpoint-inhibitor","kind":"technology","name":"Immune checkpoint inhibitors","route":"/technologies/checkpoint-inhibitor/"},{"id":"platinum","kind":"technology","name":"Platinum agents","route":"/technologies/platinum/"}],"drug":[{"id":"atezolizumab","kind":"drug","name":"Atezolizumab","route":"/drugs/atezolizumab/"},{"id":"carboplatin","kind":"drug","name":"Carboplatin","route":"/drugs/carboplatin/"},{"id":"paclitaxel","kind":"drug","name":"Paclitaxel / nab-paclitaxel","route":"/drugs/paclitaxel/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}